Status:
NOT_YET_RECRUITING
The FMT Study for AN
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Western University, Canada
Conditions:
Anorexia Nervosa
Eligibility:
All Genders
16-35 years
Brief Summary
Anorexia Nervosa (AN) is a severe, debilitating and potentially life threatening illness that is difficult to treat. A cardinal symptom of AN is the mistaken belief on the part of the individuals that...
Detailed Description
The overall objective is to determine FMT's acceptability and the extent and means by which it helps patients with AN, restricting type. The investigators hypothesize that FMT will lead to diversifica...
Eligibility Criteria
Inclusion
- meet DSM 5 criteria for AN, restricting type, moderate or higher severity, as indicated by a BMI\<17
- Participants must we willing and able to swallow FMT capsules without vomiting
- Able to read and understand conversational English
Exclusion
- Medical or psychiatric instability needing hospitalization
- Patients with AN binge/purge type
- Use of antibiotics or probiotics in the month prior to treatment
- Regular oral steroid use, or potent topical steroid use on large sections of skin
- Chronic immune compromise and chronic illness affecting the intestinal tract or metabolic health
- Pregnancy or intended pregnancy over the time of study
- Patients enrolled in any treatment program that involves refeeding
Key Trial Info
Start Date :
September 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07143981
Start Date
September 15 2025
End Date
August 31 2026
Last Update
August 27 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.